Pre-Existing Autoimmune Disease Increases the Risk of Cardiovascular and Noncardiovascular Events After Immunotherapy

Lee, C., Drobni, Z. D., Zafar, A., Gongora, C. A., Zlotoff, D. A., Alvi, R. M., Taron, J., Rambarat, P. K., Schoenfeld, S., Mosarla, R. C., Raghu, V. K., Hartmann, S. E., Gilman, H. K., Murphy, S. P., Sullivan, R. J., Faje, A., Hoffmann, U., Zhang, L., Mayrhofer, T., … Neilan, T. G. (2022). Pre-Existing Autoimmune Disease Increases the Risk of Cardiovascular and Noncardiovascular Events After Immunotherapy. JACC: CardioOncology, 4(5), 660–669. https://doi.org/10.1016/j.jaccao.2022.11.008
Authors:
Charlotte Lee
Zsofia D Drobni
Amna Zafar
Carlos A Gongora
Daniel A Zlotoff
Raza M Alvi
Jana Taron
Paula K Rambarat
Sara Schoenfeld
Ramya C Mosarla
Vineet K Raghu
Sarah E Hartmann
Hannah K Gilman
Sean P Murphy
Ryan J Sullivan
Alexander Faje
Udo Hoffmann
Lili Zhang
Thomas Mayrhofer
Kerry L Reynolds
Tomas G Neilan
Affiliated Authors:
Charlotte Lee
Author Keywords:
coronary artery disease
immunotherapy
myocarditis
thrombosis
cabg, coronary artery bypass graft
ctla-4, cytotoxic t lymphocyte–associated antigen-4
cv, cardiovascular
dvt, deep venous thrombosis
ici, immune checkpoint inhibitor
mi, myocardial infarction
pci, percutaneous coronary intervention
pd-1, programmed death-1
pd-l1, programmed death-ligand 1
pe, pulmonary embolism
smd, standardized mean difference
tia, transient ischemic attack
irae, immune-related adverse event
Publication Type:
Article
Unique ID:
10.1016/j.jaccao.2022.11.008
PMID:
Publication Date:
Data Source:
PubMed

Record Created: